From: A new paradigm evaluating cost per cure of HCV infection in the UK
Parameter | OR | 95 % Wald Confidence Limits | Standard Error | P value | |
---|---|---|---|---|---|
Age | 0.94 | 0.90 | 0.99 | 0.03 | 0.02 |
Gender | 1.20 | 0.49 | 2.93 | 0.23 | 0.69 |
Female (vs male) | |||||
Liver disease | 0.35 | 0.13 | 0.94 | 0.25 | 0.04 |
Cirrhosis (vs no cirrhosis) | |||||
Treatment status | 0.84 | 0.35 | 1.99 | 0.22 | 0.69 |
Experienced (vs naïve) | |||||
HIV co-infection (n = 10) | 2.56 | 0.44 | 14.77 | 0.45 | 0.29 |
Absence (vs presence) | |||||
Depression (n = 40) | 0.88 | 0.35 | 2.22 | 0.24 | 0.79 |
Absence (vs presence) | |||||
Diabetes (n = 8) | 4.94 | 0.62 | 39.56 | 0.53 | 0.13 |
Absence (vs presence) | |||||
IL28b | 0.12 | 0.04 | 0.37 | 0.29 | 0.0002 |
Non-CC (vs CC) | |||||
Genotype | 1.09 | 0.37 | 3.22 | 0.29 | 0.28 |
G1a (vs G1b) | |||||
Race | 0.31 | 0.04 | 2.42 | 0.52 | 0.27 |
Other (vs white) |